1. Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer
   Vineet Talwar et al, 2020, Indian Journal of Medical Research CrossRef
2. Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
   Sujin Park et al, 2023, Journal of Pathology and Translational Medicine CrossRef
3. Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer
   Hidehiro Tajima et al, 2017, Molecular and Clinical Oncology CrossRef
4. Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line
   ATSUSHI HIROSE et al, 2013, Oncology Letters CrossRef
5. Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer
   Hidehiro Tajima et al, 2018, Molecular and Clinical Oncology CrossRef
6. Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
   Helga Weber et al, 2015, Oncotarget CrossRef